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HTLV-1 is the etiological agent of two different types of diseases:
adult T-cell leukemia/lymphoma (ATLL), an aggressive T-cell neo-
plasm (Uchiyama et al., 1977), and tropical spastic paraparesis/HTLV-
associated myelopathy (TSP/HAM) (Gessain et al., 1985), a progres-
sive demyelinating disease that targets mainly the thoracic spinal
cord. ATLL and TSP/HAM arise in a minority (3–5%) of infected
individuals after a latency period ranging from years (TSP/HAM) to
decades (ATLL).
Both CD4+ and CD8+ T cells are infected by HTLV-1 in vivo. After a
short period of primary infection characterized by a burst of reverse-
transcription-based replication, a pool of ~0.1% to ~10–20% of
lymphoid cells remains persistently infected (Bangham et al., 2009).
T-cell clones, in each of which all daughter cells derive from an
infected progenitor cell, are thus themain reservoir for HTLV-1 in vivo.These clones are persistently expanded since they can be regularly
detected during the lifespan of infected individuals (Cavrois et al.,
1998). Cells within these clones are selected for their ability to express
the HTLV-1 encoded tax gene in vivo (Zane et al., 2010) and display
high-level genetic instability, as evidenced by high somatic mutation
loads (Mortreux et al., 2001b). ATLL is the malignant transformation
of a persistently expanding CD4+ clone, whereas in TSP/HAM,
infected and uninfected CD4+ and CD8+ cells inﬁltrate and damage
the spinal cord (Hara et al., 1994).
We recently investigated the mechanisms underlying the clonal
expansion of HTLV-1 infected cells in vivo (Sibon et al., 2006). To this
end we designed an ex vivo model of clonal expansion based on the
culture of T cells deriving from infected individuals and cloned
through limiting dilution. This permitted to demonstrate that the
clonal expansion of HTLV-1 positive CD8+ and CD4+ lymphocytes
involves two distinct mechanisms: infection prevents cell death in
CD8+ lymphocytes whereas recruiting CD4+ lymphocytes into the
cell cycle (Zane et al., 2009).
The HTLV-1-encoded proteins Tax (Boxus et al., 2008), p12, and p13
target multiple pathways governing cell death (reviewed in Saggioro et
al., 2009). Tax enhances cell survival through its effects on the NF-KB
(Kawakami et al., 1999; McKinsey et al., 1996), CREB (Kwok et al., 1996;
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pathways and the tumor suppressors p53 (de la Fuente et al., 2003; Pise-
Masison et al., 1998) and RB (Haller et al., 2002; Kehn et al., 2005). The
accessory protein p13 is targeted to the inner mitochondrial membrane
and sensitizes cells to death stimuli involving this organelle (D'Agostino
et al., 2005), suchas the Fas/ceramidepathway (Silic-Benussi et al., 2004)
and reactive oxygen-species (ROS)-mediated cell death (Silic-Benussi et
al., 2009). P12 enhances the release of calcium from the endoplasmic
reticulum and therefore may inﬂuence calcium-dependent apoptotic
signals, including the opening of the mitochondrial permeability pore
(Kim et al., 2003).
Having evidenced that the clonal expansion of infected CD8+
lymphocytes relies on reduced cell death, we aimed at dissecting the
mechanisms underlying apoptosis blockade in these cells in vivo. To
this end we cloned peripheral blood mononuclear cells (PBMCs) from
infected patients without malignancy. This allowed to compare
naturally infected CD4+ and CD8+ clones to their uninfected
counterparts for resistance to cell death, apoptosis regulation, and
gene expression. We ﬁrst demonstrated that upon infection, cloned
CD8+ cells but not CD4+ cells from infected patients without
malignancy acquire resistance to Fas-mediated cell death. Results of
microarray analyses conﬁrmed by real-time quantitative PCR revealed
that only a restricted subset of genes involved in apoptosis is
speciﬁcally deregulated in infected CD8+ clones deriving from
patients. Among these, the two antiapoptotic genes cIAP-2 (cellular
inhibitor of apoptosis 2) (Roy et al., 1997) and c-FLIP (FLICE-inhibitory
protein) (Krueger et al., 2001) were found to be speciﬁcally over-
expressed in infected CD8+ clones. However, in the present model of
clonal expansion, cIAP-2 but not c-FLIP could be linked to the resistanceof
naturally infected CD8+ clones to apoptosis. This phenomenon was
found to be dependent on tax expression via NF-KappaB. Therefore,
cIAP-2 seems to be involved in the CD8+-associated dissemination and
persistence of the virus in vivo.
Results
HTLV-1 positive CD8+ cloned lymphocytes from patients with TSP/HAM
resist Fas-mediated cell death
HTLV-1 positive cell lines and tax expressing cells resist death
receptor-mediated apoptosis (induced by anti-Fas IgM and tumor
necrosis factor-related apoptosis-inducing ligand) (Arai et al., 1998;
Hamasaki et al., 2001). Although circulating CD4+ cells from patients
with TSP/HAM are known to resist etoposide killing, as compared to
CD4+ cells from uninfected controls (Hamasaki et al., 2001), little is
known about the sensitivity of infected versus uninfected CD8+ or
CD4+ cells deriving from infected individuals. We thus compared the
effect of HTLV-1 infection on cell death between CD4+ and CD8+
cloned T cells by treating these cells with anti-Fas antibody and
recombinant human FasL. Agonistic anti-Fas antibody did not
inﬂuence the mortality of MT4 cells whereas it induced 98% of
speciﬁc cell death in Jurkat cells (not shown). Seventy-nine clones (39
CD4+, 40 CD8+) were investigated at day 6 from PHA stimulation and
overall, the mean percentages of Fas-mediated speciﬁc cell death in
CD4+ and CD8+ cloned cells from patients with TSP/HAM were 73%
and 52.4%, respectively. The level of Fas-speciﬁc cell death appeared
signiﬁcantly higher in CD4+ than in CD8+ clones (Fig. 1A and B,
p=0.002, Mann–Whitney test). As shown in Fig. 1B, there was no
signiﬁcant difference in the degree of speciﬁc Fas-mediated cell death
between the 15 infected and the 24 uninfected cloned CD4+ cells
(means 78.1% versus 70.6%). Conversely, the 23 HTLV-1 positive CD8+
clones displayed a signiﬁcantly lower level of speciﬁc Fas-mediated
cell death when compared to the 17 uninfected CD8+ clones: 63.6%
versus 44.18%, p=0.0376 (Mann–Whitney test). To conﬁrm these
results we tested the sensitivity of the same cloned T cells to
recombinant human FasL (FasL). Incubation of HTLV-1+ CD8+ cellsfor 24 h with FasL (100 ng/ml) caused up to a 3-fold decrease in
apoptosis when compared to uninfected CD8+ clones, whereas
infected and uninfected CD4+ clones displayed the same sensitivity
to FasL (not shown). Resistance to Fas-mediated cell death was
signiﬁcantly higher in tax+ than in tax− CD8+ clones (p=0.047
between tax+ and tax− CD8+ clones, Mann–Whitney test, Fig. 1B)
whereas tax+ and tax− CD4+ T cell clones displayed the same level of
apoptosis after incubation with agonistic anti-Fas antibody or with
FasL (Fig. 1B). From these data we concluded that in the present
model of clonal expansion, HTLV-1 infection and tax expression
trigger the resistance of CD8+ but not that of CD4+ cells to speciﬁc
Fas-mediated cell death.
Cloned HTLV-1 infected CD8+ cells possess an antiapoptotic transcriptome
Gene dysregulation is the hallmark of HTLV-1 infected cells
(Matsuoka and Jeang, 2007). We reasoned that changes in gene
expression might participate to the resistance of infected CD8+ cells to
cell death. Accordingly we investigated the consequences of HTLV-1
infection for themain apoptotic genes in CD4+ and CD8+ cells harvested
at day6 fromPHAstimulation. Among the55,000humanoligonucleotide
probes of the CLUHWGbioarrays, 862 corresponded to genes involved in
apoptosis, as identiﬁed by the Pathway Studio 6.2 software (Ariadne
Genomics, Rockville, MD). Their expressionwas assayedwith infected or
uninfected; CD4+ or CD8+ clones (three clones of each category) as
detailed in theMaterials andmethods section. Of these 862 genes, 70 and
34 were found deregulated upon infection in CD4+ and CD8+ clones,
respectively (Fig. 2). Canonical pathways analysis using the Ingenuity
Pathways Analysis (IPA) library identiﬁed two apoptotic pathways that
were most signiﬁcant to the data set. They corresponded to the
“apoptosis signaling” and “death receptor signaling” pathways deﬁned
by the IPA software (Ingenuity Systems, Redwood City, CA). Genes from
the data set that met the fold change cutoff of 1.3 (see Materials and
methods section) andwere associated with these canonical pathways in
the Ingenuity Pathways Knowledge Base are represented in Table 1.
Quantitative RTPCR was carried out for 8 of these 13 genes in 7 of the 12
clones analyzed by microarray. Results of qRTPCR and microarrays were
consistent in all cases. It is evident from Table 1 that the consequences of
infection on the apoptotic pathway were signiﬁcantly distinct between
CD4+ and CD8+ clones. In CD8+ cells, infection shifted gene expression
toward an antiapoptotic phenotype. For example, infected CD8+ clones
underexpressed proapoptotic genes such as FasL and PRKCQ while
overexpressing antiapoptotic genes such as c-FLIP, cIAP-2, and N-
ras. Conversely the pattern of gene expression generated by the
infection of CD4+ cells ﬁtted less with apoptosis resistance.
Although these cells overexpressed c-FLIP and cIAP-2 and under-
expressed PRKCQ, they also overexpressed proapoptotic genes such
as Apo2L/TRAIL, cdc2 and caspase-3. From these results we
concluded that upon infection, cloned CD8+ but not CD4+ cells
acquire a pattern of gene expression consistent with their
antiapoptotic phenotype.
CD8+ but not CD4+ T cells overexpress cIAP-2, c-FLIP(L), and LMNA
upon HTLV-1 infection
To conﬁrm and extend results from microarray experiments, we
next measured the expression of the proapoptotic and antiapoptotic
deregulated genes cIAP-2, c-FLIP, N-ras, PRKCQ, FasL, Apo2L, caspase-3,
and LMNA by qRTPCR in additional CD4+ and CD8+ infected or
uninfected clones tested for gene expression at day 6 from PHA
stimulation (39 clones analyzed). c-FLIP has been previously found to
possess splicing variants with distinct effects on apoptosis (Chang et
al., 2002). Accordingly, quantitative analysis wasmadewith these two
transcripts, i.e. c-FLIP(S) and c-FLIP(L) (Fig. 3). Quantitative RTPCR
analysis revealed a wide variation in gene expression between clones
(Fig. 3), thus explaining why, in contrast to microarray results, only a
Fig. 1. HTLV-1 positive CD8+ cloned lymphocytes from patients with TSP/HAM resist speciﬁc Fas-mediated cell death. Cloned CD4+ and CD8+ T cells (79 clones: CD4+HTLV1−
n=24, CD4+HTLV1+ n=15, CD8+HTLV1− n=17, CD8+HTLV1+ n=23) from patients with TSP/HAM were collected at day 6 from PHA stimulation and treated with anti-Fas
antibody as detailed in the Materials and methods section. A: for each sample analyzed, FACScan analysis allowed to characterized the cells as viable (AnnV−/PI−), early apoptotic
(AnnV+/PI−), late apoptotic (AnnV+/PI+) or dead (AnnV−/PI+). B: red squares and triangles represent infected clones with detectable tax expression, as evidenced by qRTPCR.
Horizontal lines represent the median of cell death values *p=0.0376 for speciﬁc Fas-mediated cell death in infected versus uninfected CD8+ clones, **p=0.047 for speciﬁc Fas-
mediated cell death in tax+ versus tax− infected CD8+ clones.
343L. Zane et al. / Virology 407 (2010) 341–351subset of comparisons reached statistical signiﬁcance (Fig. 3). PRKCQ,
for instance, was signiﬁcantly underexpressed upon infection in CD4+
clones while cIAP-2, c-FLIP(L) and LMNA were signiﬁcantly over-
expressed in infected CD8+ clones (Fig. 3). The expression of the six
remaining genes, as measured by qRTPCR, was not signiﬁcantly
different between infected and uninfected CD4+ or CD8+ clones.
Given the differences described, we assumed that the overexpression
of cIAP-2, c-FLIP(L) and LMNA best distinguished the effects of
infection between CD4+ and CD8+ clones. Interestingly, both cIAP-2
and c-FLIP have recently been found to be overexpressed in tax
positive cell lines in which they protect from Fas-mediated cell death
(Krueger et al., 2006; Okamoto et al., 2006; Waldele et al., 2006).
Together with the correlation between tax expression and theresistance of CD8+ T cells to Fas-mediated cell death, these qRTPCR
ﬁndings led us to reconsider, in the present model, the implication of
the two genes in vivo in the context of untransformed CD4+ versus
CD8+ infection and clonal expansion.
CD8+ lymphocyte-restricted cIAP-2 overexpression correlates with
resistance to Fas-mediated apoptosis and depends on tax expression
via NF-KappaB.
CIAP-2 prevents cell death by inhibiting caspases 3, 7, and 9
(Deveraux et al., 1998; Roy et al., 1997). Its expression parallels that of
tax in HTLV-1 positive cell lines (Waldele et al., 2006) while in the
HTLV-1 negative Jurkat cell line, ectopic tax expression triggers cIAP-2
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Fig. 2. Cloned HTLV-1 infected CD8+ cells possess an antiapoptotic transcriptome. The Venn diagram (A) illustrates the distribution of apoptosis-related genes deregulated in cloned
CD4+ or CD8+ cells upon infection. Cells were tested at day 6 from PHA stimulation. The proportion of up- versus down-regulated genes is shown in B. (C) Differentially regulated
genes of the death receptor signaling pathway in infected CD4+ and CD8+ cells versus uninfected CD4+ and CD8+ cells deriving from the same individuals were delineated by
oligonucleotide microarray analysis, followed by data analysis andmodiﬁed graphical display using the Ingenuity Pathway software as detailed in the Materials and methods section
(for further information, see also www.ingenuity.com). Gene overexpression is shown in pink, down-regulation in green.
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sub-G1 cells due to the inhibition of caspases 3 and 7 (Waldele et al.,
2006). Here we found that the level of cIAP-2 expression was
signiﬁcantly higher in infected than in uninfected CD8+ cloned T
cells (Fig. 3). In T-cell clones deriving from patients with TSP/HAM,
there was a signiﬁcant negative correlation between cIAP-2 expres-
sion and Fas-mediated apoptosis in infected CD8+ clones (R=−0.5,
p=0.028, Spearman rank correlation) but not in infected CD4+ or in
uninfected CD4+ and CD8+ clones. Furthermore, a signiﬁcant positive
correlation was found between tax and cIAP-2 expression in CD8+
(R=0.708, P=0.005, Spearman rank correlation) and CD4+ cells
(R=0.779, p=0.005, Spearman rank correlation). To date, the effect
of tax on cIAP-2 expression and function has not been investigated in
cells infected by a full-length virus. We therefore explored the link
between tax and cIAP-2 expression by expressing tax speciﬁc shRNAs
using lentiviral vectors in the tax expressing MT4 cells, which harbor
full-length integrated proviruses. VSV-G-pseudotyped viruses were
produced in 293T cells by cotransfection of the shRNA-containing
lentiviral vector backbone with expression plasmids for Gag, Pol, and
VSV-G. The same vector expressing a nonsense shRNA was used in
parallel for control. Transduction experiments were performed inquadruplicate. The effect of the transduced shRNA on tax and cIAP-2
expressions was analyzed by qRTPCR 60 h after shRNA gene
transduction. As shown in Fig. 4A and B, signiﬁcantly reduced levels
of both tax RNA and cIAP-2mRNAwere found in all shRNA-containing
cells. Caspase 3 activity is a central event in apoptosis induction (Yuan
et al., 1993) and, as such; it allows indirect measurement of apoptosis
rates. Since cIAP-2 functions by binding and inhibiting caspase 3
(Deveraux et al., 1998; Roy et al., 1997), we sought to determine
caspase 3 activity. MT4 cells were treated with cIAP-2-speciﬁc shRNAs
which inhibited cIAP-2 expression (Fig. 4D). Fig. 4D shows a
signiﬁcant increase of caspase 3 activity in shRNAs-cIAP-2-containing
HTLV-1 positive cells. Finally we conﬁrmed that the tax-mediated
cIAP-2 expression depended on NF-KappaB in MT4 cells (not shown)
as in in vivo infected CD8+ cells. To this end, four CD8+ infected clones
exhibiting various amounts of taxmRNAwere incubated with the NF-
KappaB inhibitor LLnL (1 μM) (Matsuda et al., 2005) and then assayed
for cIAP-2 expression using qRTPCR. Fig. 5A shows that LLnL decreased
cIAP-2 expression in the tax negative CD8+ clone YB33, a result
consistent with the known NF-KappaB-dependent transcription of
cIAP-2 (Hubinger et al., 2004; Schoemaker et al., 2002). In tax positive
CD8+ clones, LLnL signiﬁcantly decreased cIAP-2 expression (Fig. 5A)
Table 1
Gene differentially expressed between infected and uninfected cloned T cells and
associated with the apoptosis signaling and death receptor signaling pathways deﬁned
by the Ingenuity Pathways Knowledge Base.
Gene name Synonym Fold
change
Accession number
Genes differentially expressed in CD4+ infected clones
Apo2L Apo-2 ligand, TRIAL, TNFS10 2.3 NM_003810; AI376429
c-FLIP CFLAR 4.02 NM_003879
Caspase-3 CASPASE-3 2.95 NM_032991; NM_004346
Cdc2 Cdc2a, CDK1 7.52 NM_001786; NM_182962
clAP-2 HIAP, BIRC3 4.26 NM_001165; NM_182962
IKBKE IKK epsilon 2.00 NM_014002
LMNA LAMIN A/C 13.54 NM_005572; NM_170707;
NM_1707
NFKBIA I KAPPA B ALPHA 4.35 NM_020529
NFKBIB I-KAPPA-B BETA 1.76 NM_002503; NM_001001716
PRKCQ PKC-THETA −2.29 NM_00627
Genes differentially expressed in CD8+ infected clones
c-FLIP CFLAR 4.68 NM_003879
cIAP-2 HIAP1,BIRC3 7.07 NM_001165; NM_182962
FasL CD95L, FAS-L, TNFS6 −3.57 NM_000639
LMNA LAMIN A/C 9.47 NM_005572; NM_170707;
NM_1707
N-ras c-N-ras 2.6 NM_002524
NFKBIA I KAPPA B ALPHA 5.0 NM_020529
NFKB2 P100, P49, p49/p100, p50 3.1 NM_002502
PRKCQ PKC-THETA −4.98 NM_006257
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clones, the inhibitory effect of LLnL on cIAP-2 expression increased as a
function of tax expression (Fig. 5B and C): there was a 30% decrease in
cIAP-2 expression between the clones YB-33 and YB-207D which
respectively expressed the lowest (0 AU) and the highest (0.88 AU)
amounts of taxmRNA.
Fig. 5C illustrates the correlation between tax and cIAP-2 expres-
sions in CD8+ HTLV-1 positive clones in the presence (1 μM) or
absence of the NF-KappaB inhibitor LLnL. The ﬁgure shows that LLnL
signiﬁcantly decreased the slope of the curve, suggesting that in vivo,
the tax-dependent expression of cIAP-2 depends on NF-KappaB. This
suggests that upon infection, CD8+ lymphocytes speciﬁcally over-
express cIAP-2 in a tax-dependent manner via NF-KappaB. From these
results we concluded that in the present model, cIAP-2 expression
correlates with tax expression and resistance of cloned lymphocytes
to receptor-mediated apoptosis in infected CD8+ clones but not in
other infected or uninfected cells.CD8+ lymphocyte-restricted c-FLIP overexpression does not correlate
with resistance to apoptosis, yet depends on tax expression in a
phenotype- and splice variant-dependent manner
c-FLIP is one of themajor regulators of Fas-mediated apoptosis at the
DISC level (for review see Krueger et al., 2001). c-FLIP(L), but also c-FLIP
(S) have been found to be overexpressed in Tax expressing cell lines
(Krueger et al., 2006). Upon ectopic Tax expression, both resistance to
Fas-mediated apoptosis and induction of c-FLIP are dependent on Tax
(Krueger et al., 2006; Okamoto et al., 2006). Here the level of c-FLIP(L)
expressionwas signiﬁcantly higher in infected than in uninfected CD8+
cloned T cells (Fig. 3). However, in contrast to cIAP-2 expression, there
was no signiﬁcant correlation between c-FLIP(L) or c-FLIP(S) expres-
sions and Fas-mediated cell death in CD8+ and CD4+, infected or
uninfected clones. Furthermore upon infection, the CD8+-restricted
c-FLIP(L) overexpression did not dependon tax expression in vivo. There
was even a trend for a negative correlation between tax and c-FLIP(L)
expression in CD8+T cell clones (R=−0.505, p=0.061, Spearman rank
correlation)while in these cells, a signiﬁcant negative correlation linkedtax and c-FLIP(S) expressions (R=−0.615, P=0.041, Spearman rank
correlation). Infected CD4+ clones harbored equivalent amounts of
c-FLIP(S) and c-FLIP(L) transcripts as their uninfected counterparts,
without signiﬁcant correlation between tax and c-FLIP(S) or c-FLIP(L)
expressions in these cells. From these results we concluded that, in the
present model, the interplays between tax and c-FLIPs expressions
depend on the cell phenotype and do not seem to inﬂuence the
resistance of infected cells to Fas-dependent cell death.
Discussion
For HTLV-1, apoptosis has beenmainly investigated for understand-
ing CD4+ T cell transformation (Saggioro et al., 2009). From the time
when the pathogenic clonal expansion of HTLV-1 positive CD8+ cells
was found to rely on apoptosis blockade (Sibon et al., 2006; Zane et al.,
2009), the lymphocyte phenotype of non-transformed cells has become
an important issue for investigating the interplays between HTLV-1 and
cell death in vivo. Hitherto the interplays betweenHTLV-1 and apoptosis
have beenmainly addressed in vitro in cell lines and/or inATLL cells. Our
cellularmodel of clonal expansion permitted for theﬁrst time to explore
and compare the mechanisms underlying cell death between naturally
infected but non-transformed CD4+ and CD8+ T cells and their
uninfected counterparts. Our data show that among infected and
uninfected cloned T-cells from patients without malignancy, the
infected CD8+ T cell subset is the only one that resists Fas-mediated
cell death. Strong differences distinguished the transcriptome of
uninfected CD4+ and CD8+ cells with regards to apoptotic and
antiapoptotic genes (Fig. 2A). However, upon infection, only a restricted
subset of geneswasderegulated,with considerable differences between
the two cells types (Table 1 and Fig. 3). In fact upon infection CD8+ but
not CD4+ clones acquired speciﬁc gene deregulations consistent with
their evidenced apoptosis-resistant phenotype (Sibon et al., 2006; Zane
et al., 2009). Quantitative RTPCR revealed awide variation of the level of
gene expression between clones explaining why only 42% of the
differences observed through the microarray analysis of 6 clones
(Table 1) persisted after the qRTPCR analysis of 39 clones (Fig. 3).
Among genes speciﬁcally deregulated in infected CD8+ cells, cIAP-2 and
c-FLIPwereanalyzed inmoredetails as theyplayamajor role inblocking
apoptosis and have been recently identiﬁed as Tax targets in cell lines
(Krueger et al., 2006; Okamoto et al., 2006; Waldele et al., 2006). We
conﬁrmed in vitro and evidenced for the ﬁrst time ex vivo that cIAP-2
expression depends on tax expression via NF-Kappa B and correlates
with cell resistance to receptor-mediated cell death in CD8+ but not in
CD4+ clones deriving from naturally infected individuals without
malignancy. On the contrary, c-FLIP expressionwas inversely correlated
with tax expression in HTLV-1 positive CD8+ cells from patients and did
not correlate with resistance to cell death. Therefore one can propose
that cIAP-2 expression is important for speciﬁcally stimulating infected
CD8+ cell expansion in vivo.
Our cellular model of ex vivo clonal expansion selects in vivo
persistently expanded clones. We previously demonstrated that after
cloning, the proportion of infected CD4+ and CD8+ cloned cells
reﬂects the proviral load in vivo (Sibon et al., 2006) and that cloned
HTLV-1 positive cells correspond to persistently infected cells in vivo
(Zane et al., 2010). This suggests that the present strategy does not
introduce a signiﬁcant bias with respect to the persistent clonal
expansion that sustains the proviral load in vivo. However we
previously evidenced with the BLV system that primary infection
generates a huge excess of infected clones and that the number of
these signiﬁcantly decreases over time (Pomier et al., 2008, 2009).
This suggests that in vivo, primary infection might select for
apoptosis-resistant clones that the present strategy is unable to
isolate.
Resistance to cell death is the hallmark of HTLV-1 positive or tax-
expressing cell lines and depends on tax expression (Arai et al., 1998;
Hamasaki et al., 2001) while other HTLV-1 accessory proteins also
Fig. 3. CD8+ but not CD4+ T cells overexpress cIAP-2, c-FLIP(L), and LMNA upon HTLV-1 infection. The expression of the 9 genes was measured by qRTPCR in infected and uninfected
CD4+ and CD8+ clones (39 clones: CD4+HTLV1− n=11, CD4+HTLV1+ n=11, CD8+HTLV1− n=6, CD8+HTLV1+ n=11) at day 6 from PHA stimulation and as detailed in the
Materials andmethods section. Horizontal lines represent themedian of the expression level. Circles and squares represent the level of gene expression in uninfected versus infected
cells, while red square correspond to tax positive clones as assessed by qRTPCR.
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Fig. 4. cIAP-2 expression depends on tax expression and inhibits caspase 3. MT4 cells were
transduced with a tax-speciﬁc shRNA that decreased both tax (A) and cIAP-2. (B) When
compared with the control shRNA, the 3 cIAP-2-speciﬁc ShRNAs TRC3775, TRC3776, and
TRC3777 decreased cIAP-2 expression (C) and increased caspase 3 activity (D). Data shown
are the means (±standard deviation) of one representative experiment performed in
quadruplicate.
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2009). Primary CD4+ lymphocytes deriving from patients with TSP/
HAM resistmitochondrial-dependent cell death (Hamasaki et al., 2001)
while peripheral T cells from env-pX transgenic mice resist Fas-
mediated cell death (Kishi et al., 1997). Our model allowed for the
ﬁrst time to compare resistance to cell death in infected and uninfected
CD4+ and CD8+ cells deriving from naturally infected individuals.
Overall, cloned CD8+ T cells appearedmore resistant than cloned CD4+
cells to Fas-mediated cell death. However, upon infection, only CD8+ T
cell clones increased their resistance to Fas-mediated cell death, a result
in line with our previous ﬁndings of HTLV-1-based prevention of cell
death in CD8+ but not in CD4+ cells deriving from patients without
malignancy (Sibon et al., 2006; Zane et al., 2009).
Microarray and qRTPCR analyses of infected and uninfected clones
identiﬁed a restricted number of genes involved in apoptosis and
speciﬁcally deregulated in CD8+ T-cell clones. Among these, c-FLIP
and cIAP-2 are known to be up regulated by Tax in vitro (Krueger et al.,
2006; Okamoto et al., 2006;Waldele et al., 2006). Given that the effect
of these genes has not been investigated in the context of naturally
infected CD4+ or CD8+ cells and that in our model resistance of
infected CD8+ T cells to cell death correlated with tax expression, we
investigated the role of cIAP-2 and c-FLIP in cell death resistance in
CD4+ versus CD8+ infected and uninfected cells deriving from
patients with TSP/HAM.
The interplays between Tax, NF-KappaB and cIAP-2 expressions
have been previously evidenced in tax transfected cell lines (Waldele
et al., 2006). As other viral proteins might interfere with tax in gene
regulation (Matsuoka and Jeang, 2007) we investigated the effect of
Tax on cIAP-2 expression in MT4 cells that carry full-length integrated
proviruses and express tax. Tax shRNA reduced cIAP-2 expression in
these cells and cIAP-2 down-regulation increased caspase 3 activity.
Furthermore, LLnL experiments permitted to link the effect of tax
expression on cIAP-2 expression with NF-Kappa B in both MT4 cells
and cloned CD8+ T cells from patients. There was no link betweencIAP-2 expression and resistance to cell death in uninfected CD4+ and
CD8+ cells. Interestingly, although both infected CD4+ and CD8+
clones displayed strong correlations between tax and cIAP-2 expres-
sions in vivo, cIAP-2 expression correlated with Fas-dependent cell
death resistance in CD8+ but not in CD4+ infected clones. This
suggests that additional phenotype-speciﬁc factors might contribute
in vivo to triggering cIAP-2-based cell death resistance in HTLV-1
infected lymphocytes.
HTLV-1 cell lines express high levels of both c-FLIP(L) and c-FLIP(S)
mRNA while the ectopic expression of tax in Jurkat cells augments c-
FLIP expression and triggers resistance to Fas-mediated cell death
(Krueger et al., 2006). Microarray analyses of cloned T cells from
patients with TSP/HAM were consistent with an overexpression of c-
FLIP in both CD4+ and CD8+ infected clones (Table 1) while qRTPCR
demonstrated that upon infection, the expression c-FLIP(L), but not
that of c-FLIP(S) was signiﬁcantly augmented in CD8+ clones but not
in CD4+ clones. However the expression of c-FLIP, in contrast to that of
cIAP-2, did not correlate with the resistance of infected or uninfected
CD4+ and CD8+ T cell clones to receptor-mediated cell death.
Together these results did not support a central role for c-FLIP in the
clonal expansion of infected CD8+ lymphocytes in vivo.
In conclusion naturally HTLV-1 infected cells display profound
differences in their resistance to apoptosis according to their CD4+
versus CD8+ phenotype. The restricted resistance of infected CD8+ T
cells to Fas-mediated apoptosis is consistent with the known route of
infected CD8+ T cell clonal expansion, which involves the prevention
of HTLV-1-based cell death. A combination of gene deregulations
helps explain this CD8+-restricted phenotype and, among the genes
found deregulated in infected CD8+ cells, cIAP-2 but not c-FLIP seems
to play an important role for preventing cell death. Besides, our
comparative analysis of CD4+ and CD8+ clones deriving from patients
reveals that infection and tax expression might have strongly distinct
effects on cellular gene expression and cell behavior in vivo, according
to the lymphocyte phenotype. Finally, as infected CD8+ clonal
expansion allows for virus persistence (Nagai et al., 2001; Sibon et
al., 2006), virus dissemination (Cavrois et al., 2000; Mortreux et al.,
2001a), impairment of anti-HTLV-1 cellular immune response (Hanon
et al., 2000) and tissue damage (Hara et al., 1994), the present results
obtained in naturally infected cells identify cIAP-2 expression as an
important target for treating HTLV-1 infection.
Materials and methods
Ethics statement
This study was conducted according to the principles expressed in
the Declaration of Helsinki. The study was approved by the
Institutional Review Board of the Léon Bérard anticancer center. All
patients provided written informed consent for the collection of
samples and subsequent analysis.
Samples studied
PBMCs were obtained after informed consent from two patients
with TSP/HAM. The HTLV-negative acute lymphoblastic leukemia T-
cell line Jurkat and the HTLV-1-transformed T-cell line MT4 were
propagated as described (Cavrois et al., 1995; Gabet et al., 2003).
T-cell limiting dilution cloning
PBMCs were cloned in limiting dilution (0.1 cell per well) in
Terasaki plates after removal of adherent cells. The medium used for T
lymphocyte culture was RPMI 1640 containing penicillin and
streptomycin, sodium pyruvate, non-essential amino acid solution,
2-mercapto ethanol, 10% ﬁltered human AB serum, and 100 U/ml
recombinant IL-2 (Chiron Corporation). The medium was
Fig. 5. In vivo, tax-dependent cIAP-2 expression depends on NF-KappaB. Four HTLV-1 positive CD8+ clones that express tax were incubated with the NF-KappaB inhibitor LLnL as
detailed in the Methods section. The level of tax expression (arbitrary units) is given for each clone (B). For each clone, LLnL decreased cIAP-2 expression (A) without affecting tax
expression (B). cIAP-2 expression correlates with tax expression and is signiﬁcantly decreased in the presence of LLnL (C).
348 L. Zane et al. / Virology 407 (2010) 341–351supplementedwith 1 μg/ml PHA (AbbottMurex HA 16) and 5×105/ml
irradiated (30 Gy) allogeneic PBMCs (feeder cells) for cloning. The
Terasaki plates were stored at 37 °C for 10 days in aluminum foil, then
screened for growing cells under themicroscope. Positive cultureswere
transferred to 96-well U-bottom plates in the medium used for culture
and restimulated after a few days. T lymphocytes were restimulated
every 14 days with PHA (1 μg/ml) and fresh feeder cells (106/ml).
Lethally irradiatedPBMCs fromthreedistinct allogeneicHTLV-I negative
donors were used as feeder cells to exclude the possibility of clones
becoming infected in vitro. Cloning efﬁciency was similar to previous
studies and ranged from20% to98%(Haﬂer et al., 1988; Richardsonet al.,
1997; Sibon et al., 2006; Wucherpfennig et al., 1992). To preserve the
original growth characteristics of the cells, clones were maintained for
no more than 4 months, and then fresh aliquots were thawed.Phenotypic determination
Antibodies recognizing CD4 and CD8 were purchased from
DakoCytomation. For ﬂuorescence-activated cell scanner (FACScan)
analysis, PBMCs or cloned T cells were incubated with 5% ﬁltered
human serum, then stained with antibodies. Staining and scanning
were performed in phosphate-buffered salinewith 2% fetal calf serum.
Isotype-matched controls were used. Data were acquired on aFACScan and analyzed by means of CellQuest™ software (Becton
Dickinson).Apoptosis assay
Apoptosis was assessed by using the APOPTEST™ kit (DakoCytoma-
tion) containing ﬂuorescein-conjugated annexin V, propidium iodide
and binding buffer. Cells suspended in the binding buffer were mixed
with ﬂuorescein-conjugated annexin V and propidium iodide, incubated
for 10 min, then analyzed by FACScan. By combining annexin V/FITC and
propidium iodide, three distinct phenotypes could be discriminated:
non-apoptotic live cells remained unlabeled, apoptotic cellswere labeled
by annexin V/FITC, and necrotic cells (necrosis or late apoptosis) were
labeled by both annexin V/FITC and propidium iodide (PI). For each
sample analyzed, this allowed to characterized the cells as viable
(AnnV−/PI−), early apoptotic (AnnV+/PI−), late apoptotic (AnnV+/-
PI+)ordead (AnnV−/PI+).After apoptosis inductionwith1or5 μg/mlof
agonistic anti-Fas antibody (clone CH11, Upstate Millipore) or 100 or
250 ng/ml of recombinant human FasL (Axxora Alexis Biochemicals) for
24 h, the cells were analyzed for annexin-V positivity. Speciﬁc apoptosis
was calculated as follows: (% experimental apoptosis−% spontaneous
apoptosis)/(100−% spontaneous apoptosis)×100. Caspase-3 activity
was measured by using the Caspase-3 Fluorometric Assay Kit from
349L. Zane et al. / Virology 407 (2010) 341–351Gentaurwhich utilizes theDEVD-AFC substrate. Activitywas determined
according to the manufacturer's instructions.
Lentiviral transduction of shRNA
Double-stranded oligonucleotides encoding short hairpin RNAs
(shRNAs) speciﬁc for taxwere ligated into the pLKO.1 vector digested
by AgeI and EcoRI restriction enzymes (tax oligonucleotides (target
sequence: 541–559 bp of the pX region): CCGGGCCTTCCTCAC-
CAATGTTCCTCGAGACATTGGTGAGGAAGGCTTTTTG and AATT-
CAAAAAGCCTTCCTCACCAATGTTCTCGAGGAACATTGGTGAGGAAGGC).
The shRNA vectors against cIAP-2 (TRC3775–3779), the TurboGFP
(SHC003) and non-target shRNA control (SHC002) vectors were
purchased from Sigma (Mission TRC shRNA Target Set). Vesicular
stomatitis virus-glycoprotein (VSV-G)-pseudotyped lentiviruses were
produced in HEK293T cells. For each 10-cm dish, 13.2 μg of lentiviral
pLKO vector (expressing TurboGFP or shRNAs against tax, cIAP-2 or a
non-target shRNA), 10.2 μg of pCMV8.91, and 2.64 μg of pHCMVG
expression plasmids were transfected using CalPhos mammalian
transfection kit (Clontech) in the presence of 25 μM chloroquine
(Sigma). After 2 days, the lentivirus-containing supernatant was
collected and ﬁltered through 0.45 μm syringe ﬁlters. For infection,
1.5×106 lymphocytes were incubated with the media at a vector
particle concentration of 200 ng p24/ml for 10 h in the presence of
5 μg/ml polybrene (Sigma), followed by fresh media for 48 h.
Lentivirally transduced lymphocytes were harvested for RNA analysis
and apoptosis assays.
RNA ampliﬁcation
RNA ampliﬁcation and microarray analysis have been performed
in the genomic platform ProﬁleXpert (ProﬁleXpert, Bron, France).
Total RNA was extracted from three CD4+ and three CD8+ infected
clones and from three CD4+ and CD8+ uninfected clones using an
RNeasy minikit (Qiagen, Hilden, Germany), including a DNAse
treatment and according to the manufacturer's protocol. Total RNA
yield was measured by OD260, with an A260/A280 ratio of 1.9–2.1
demonstrating purity. Quality was evaluated on nanochips with the
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA),
according to the manufacturer's protocol. Total RNA (50 ng) was then
ampliﬁed and biotin-labeled by two rounds of in vitro transcription
(dIVT) with a Message Amp aRNA kit (Ambion, Austin, TX, USA)
following the manufacturer's protocol. Before ampliﬁcation, different
concentrations (1/1000 to 1/1,000,000) of synthetic bacterial mRNA
provided in the codelink control RNA spikes kit (Applied Microarrays,
Tempe, AZ, USA) were added at a 1:20,000 mass ratio to all samples;
these positive controls were used to ascertain the quality of the
process. aRNA yieldwasmeasuredwith an UV spectrophotometer and
the quality on nanochips with the Agilent 2100 Bioanalyzer (Agilent).
Array hybridization and processing
Ten micrograms of biotin-labeled aRNA was fragmented using 5 μl
of fragmentation buffer in a ﬁnal volume of 20 μl, then mixed with
240 μl of Amersham hybridization solution (GE Healthcare Europe
GmbH, Freiburg, Germany) and injected onto CodeLink Uniset Human
Whole Genome (CLUHWG) bioarrays containing 55,000 human
oligonucleotide gene probes (GE Healthcare Europe GmbH). Arrays
were hybridized overnight at 37 °C with shaking at 300 rpm in an
incubator. The slides were washed in stringent TNT buffer at 46 °C for
1 h, then a streptavidin-cy5 (GE Healthcare) detection step was
performed. Each slide was incubated for 30 min in 3.4 ml of
streptavidin-cy5 solution as described previously (Fèvre-Montange
et al., 2006) then washed four times in 240 ml of TNT buffer, rinsed
twice in 240 ml of water containing 0.2% Triton X-100, and dried by
centrifugation at 600 rpm. The slides were scanned using a Genepix4000B scanner (Axon, Union City, USA) and Genepix software, with
the laser set at 635 mm, the laser power at 100%, and the
photomultiplier tube voltage at 60%. The scanned image ﬁles were
analyzed using CodeLink expression software, version 4.0 (GE
Healthcare), which produces both raw and normalized hybridization
signals for each spot on the array.
Microarray data analysis
The relative intensity of the raw hybridization signal on arrays
varies with the experiments. CodeLink software was therefore used to
normalize the raw hybridization signal on each array to the median of
the array (median intensity was 1 after normalization) for better
cross-array comparison. The threshold of detection was calculated
using the mean±3 SD of normalized signal intensity of the 100
negative control samples in the array; spots with signal intensities
below this threshold are referred to as “absent”. Quality of processing
was evaluated by generating scatter plots of positive signal distribu-
tion. Signal intensities were then converted to log base 2 values. For
microarray data, statistical comparison and ﬁltering were performed
using Genespring software 7.3.1 (Agilent). A ﬁrst selection of genes
was performed by pairwise comparisons between CD4+ and CD8+,
infected or uninfected clones. Each sample in a group (three CD4+ or
CD8+ infected clones) was compared with each sample in the other
group (three CD4+ or CD8+ uninfected clones), and only genes
showing a fold variation of ≥1.3 for all the comparisons were
retained. A given mRNA transcript was considered as differentially
expressed in the comparison of any two groups of samples if the
difference gave a p-value of ≤0.05 in the Welch ANOVA parametric
test, using a multiple test correction (Benjamini and Hochberg False
Discovery Rate). Thus, a gene was considered differentially expressed
only if it met the above criteria in all pairwise comparisons and if the
detected signal was above the background for at least one of the
compared groups, thereby carrying a statistically signiﬁcant absolute
score as ‘present’ or ‘marginal’ in all samples. Ingenuity Pathway
Analysis (Mountain View, CA) was used for global function analysis
and a list of the genes associated with apoptosis was generated with
MedscanReader 2.2 (Ariadne Genomics, Rockville, MD, USA) and
Pathway Studio 6.2 (Ariadne Genomics) softwares for automated
extraction of information from scientiﬁc text.
Polymerase chain reaction analysis
T-cell clones were screened for HTLV-I proviral DNA by polymer-
ase chain reaction (PCR) ampliﬁcation with LTR-speciﬁc primers, as
previously described (Saito et al., 1996). The monoclonality of
cultured cells was assessed on DNA by TCR-gamma chain gene
rearrangement analysis as previously described (Delfau-Larue et al.,
2000). Brieﬂy, all Vg-Jg combinations were ampliﬁed in a multiplex
PCR. PCR products were run on a denaturating gradient gel. A PCR
performed from a monoclonal culture produced one (monoallelic) or
two bands (biallelic). Each clone could be identiﬁed by its DGGE
migration pattern. For real-time quantitative reverse transcriptase–
polymerase chain reaction (qRTPCR), total cellular RNA from samples
was isolated using TriZol reagent according to the manufacturer's
instructions (Invitrogen Life technologies). Before reverse transcrip-
tion, RNA was treated by DNase (Invitrogen) to prevent DNA
contamination. First-strand cDNA was synthesized from 0.5 mcg
RNA using random primers (Promega) and Superscript II reverse
transcriptase (Invitrogen). RNA concentration and purity were
determined by UV spectrophotometry (nanodrop). The primer pairs
and probes were designed using the Universal Probe Library website
(Roche diagnostics). The primers of each pair were located in different
exons to avoid genomic ampliﬁcation. Primer and probe sequences for
tax (Yamano et al., 2002) and FasL were found in the literature
(Bolstad et al., 2003). HPRT-1 was used as the reference gene for the
350 L. Zane et al. / Virology 407 (2010) 341–351normalization of results. PCRs were performed using LightCycler
Taqman Master (Roche Applied Science, Basel, Switzerland) on a
LightCycler 2.0 system (Roche Applied Science, Basel, Switzerland).
The reaction mixture contained 2 μl of a 1/10 dilution of ﬁrst-strand
cDNA from cells, 4 μl of LightCycler TaqMan Master Mix 5× (contain-
ing FastStart TaqDNA polymerase, reaction buffer, deoxynucleoside
triphosphate mixture, MgCl2), 2 μl of primers and probe (primers
were used at 2 mcM and probe at 1 μM concentrations; 5 and 4 μM for
tax). The ﬁnal reaction volume was 20 μl. Thermocycling conditions
involved three consecutive steps (the thermocycling conditions of the
Roche Applied Science Universal Probe Library were used for the
reference genes). Step 1: denaturation and polymerase activation by
10 min heating at 95 °C prior to ampliﬁcation. Step 2 (45 cycles):
denaturation for 10 s at 95 °C, annealing for 30 s at 60 °C and
extension for 1 s at 72 °C. Step 3: cooling for 30 s at 40 °C for one
cycle. A large amount of cDNA was prepared from the MT4 cell line
prior to the experiment. This cDNA was 10 fold-diluted, aliquoted and
used as a calibrator for all RT-PCR runs. For relative quantiﬁcation and
normalization, the comparative Ct (or Eff-DDC) method was used
(Livak and Schmittgen, 2001).
Acknowledgments
This work was supported by the Ligue Nationale Contre le Cancer
(Comités de l'Ain, de la Drome et du Rhône), the Association pour la
Recherche sur le Cancer, the Fondation de France, the Association
Laurette Fugain, the CancéropoleLyon Auvergne Rhône-Alpes, the
Centre Léon Bérard, the Centre National pour la Recherche Scientiﬁ-
que and the Institut National de la Santé et de la Recherche Médicale.
LZ was supported by a bursary from the Association pour la Recherche
sur le Cancer and from the Ligue Nationale Contre le Cancer (comité
de la Loire). DS was supported by a bursary from the Association pour
la Recherche sur le Cancer and from the Fondation pour la Recherche
Médicale. FM is supported by Inserm. EW is supported by the Hospices
Civils de Lyon and Lyon I University. The authors thank Renaud
Mahieux (Ecole Normale Supérieure de Lyon) for helpful comments.
The authors also thankMarie-Dominique Reynaud for the preparation
of the manuscript.
References
Arai, M., Kannagi, M., Matsuoka, M., Sato, T., Yamamoto, N., Fujii, M., 1998. Expression of
FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T
cell lines derived from human T cell leukemia virus type 1-associated myelopathy/
tropical spastic paraparesis patients. AIDS Res. Hum. Retroviruses 14 (3), 261–267.
Bangham, C.R., Meekings, K., Toulza, F., Nejmeddine, M., Majorovits, E., Asquith, B.,
Taylor, G.P., 2009. The immune control of HTLV-1 infection: selection forces and
dynamics. Front. Biosci. 14, 2889–2903.
Bolstad, A.I., Eiken, H.G., Rosenlund, B., Alarcon-Riquelme, M.E., Jonsson, R., 2003.
Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T
lymphocyte-associated antigen 4, and programmed cell death 1 in primary
Sjogren's syndrome. Arthritis Rheum. 48 (1), 174–185.
Boxus, M., Twizere, J.C., Legros, S., Dewulf, J.F., Kettmann, R., Willems, L., 2008. The
HTLV-1 Tax interactome. Retrovirology 5, 76.
Cavrois, M., Gessain, A., Gout, O., Wain-Hobson, S., Wattel, E., 2000. Common human T
cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal ﬂuid and
blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical
spastic paraparesis indicate that HTLV-1 crosses the blood–brain barrier via clonal
HTLV-1-infected cells. J. Infect. Dis. 182 (4), 1044–1050.
Cavrois, M., Leclercq, I., Gout, O., Gessain, A., Wain-Hobson, S., Wattel, E., 1998.
Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected
circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated
myelopathy. Oncogene 17 (1), 77–82.
Cavrois, M., Wain-Hobson, S., Wattel, E., 1995. Stochastic events in the ampliﬁcation of
HTLV-I integration sites by linker-mediated PCR. Res. Virol. 146 (3), 179–184.
Chang, D.W., Xing, Z., Pan, Y., Algeciras-Schimnich, A., Barnhart, B.C., Yaish-Ohad, S.,
Peter, M.E., Yang, X., 2002. c-FLIP(L) is a dual function regulator for caspase-
8 activation and CD95-mediated apoptosis. EMBO J. 21 (14), 3704–3714.
D'Agostino, D.M., Silic-Benussi, M., Hiraragi, H., Lairmore, M.D., Ciminale, V., 2005. The
human T-cell leukemia virus type 1 p13II protein: effects onmitochondrial function
and cell growth. Cell Death Differ. 12 (Suppl 1), 905–915.
de la Fuente, C., Wang, L., Wang, D., Deng, L., Wu, K., Li, H., Stein, L.D., Denny, T., Coffman,
F., Kehn, K., Baylor, S., Maddukuri, A., Pumfery, A., Kashanchi, F., 2003. Paradoxicaleffects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax
expressing cells. Mol. Cell. Biochem. 245 (1–2), 99–113.
Delfau-Larue, M.H., Laroche, L., Wechsler, J., Lepage, E., Lahet, C., Asso-Bonnet, M., Bagot,
M., Farcet, J.P., 2000. Diagnostic value of dominant T-cell clones in peripheral blood
in 363 patients presenting consecutively with a clinical suspicion of cutaneous
lymphoma. Blood 96 (9), 2987–2992.
Deveraux, Q.L., Roy, N., Stennicke, H.R., VanArsdale, T., Zhou, Q., Srinivasula, S.M., Alnemri, E.
S., Salvesen, G.S., Reed, J.C., 1998. IAPs block apoptotic events induced by caspase-8 and
cytochrome c by direct inhibition of distinct caspases. EMBO J. 17 (8), 2215–2223.
Fèvre-Montange, M., Champier, J., Szathmari, A., Wierinckx, C., Mottolese, C., Guyotat, J.,
Figarella-Branger, D., Jouvet, A., Lachuer, J., 2006. Microarray analysis reveals
differential gene expression patterns in tumors of the pineal region. J. Neuropathol.
Exp. Neurol. 65 (7), 675–684.
Gabet, A.S., Mortreux, F., Charneau, P., Riou, P., Duc-Dodon,M.,Wu, Y., Jeang, K.T., Wattel, E.,
2003. Inactivation of hTERT transcription by Tax. Oncogene 22 (24), 3734–3741.
Gessain, A., Barin, F., Vernant, J.C., Gout, O., Maurs, L., Calender, A., de The, G., 1985.
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic
paraparesis. Lancet 2 (8452), 407–410.
Haﬂer, D.A., Duby, A.D., Lee, S.J., Benjamin, D., Seidman, J.G., Weiner, H.L., 1988.
Oligoclonal T lymphocytes in the cerebrospinal ﬂuid of patients with multiple
sclerosis. J. Exp. Med. 167 (4), 1313–1322.
Haller, K., Wu, Y., Derow, E., Schmitt, I., Jeang, K.T., Grassmann, R., 2002. Physical interaction
of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates
the phosphorylation of retinoblastoma protein. Mol. Cell. Biol. 22 (10), 3327–3338.
Hamasaki, S., Nakamura, T., Furuya, T., Kawakami, A., Ichinose, K.,Nakashima, T., Nishiura, Y.,
Shirabe, S., Eguchi, K., 2001. Resistance of CD4-positive T lymphocytes to etoposide-
induced apoptosis mediated by upregulation of Bcl-xL expression in patients with
HTLV-I-associated myelopathy. J. Neuroimmunol. 117 (1–2), 143–148.
Hanon, E., Asquith, R.E., Taylor, G.P., Tanaka, Y., Weber, J.N., Bangham, C.R., 2000. High
frequency of viral protein expression in human T cell lymphotropic virus type 1-
infected peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 16 (16),
1711–1715.
Hara, H., Morita, M., Iwaki, T., Hatae, T., Itoyama, Y., Kitamoto, T., Akizuki, S., Goto, I.,
Watanabe, T., 1994. Detection of human T lymphotrophic virus type I (HTLV-I)
proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord
lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Exp. Med.
180 (3), 831–839.
Hubinger, G., Schneider, C., Stohr, D., Ruff, H., Kirchner, D., Schwanen, C., Schmid, M.,
Bergmann, L., Muller, E., 2004. CD30-induced up-regulation of the inhibitor of
apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells. Exp.
Hematol. 32 (4), 382–389.
Kawakami, A., Nakashima, T., Sakai, H., Urayama, S., Yamasaki, S., Hida, A., Tsuboi, M.,
Nakamura, H., Ida, H., Migita, K., Kawabe, Y., Eguchi, K., 1999. Inhibition of caspase
cascade by HTLV-I tax through induction of NF-kappaB nuclear translocation. Blood
94 (11), 3847–3854.
Kawakami, H., Tomita, M., Okudaira, T., Ishikawa, C., Matsuda, T., Tanaka, Y., Nakazato, T.,
Taira, N., Ohshiro, K., Mori, N., 2007. Inhibition of heat shock protein-90 modulates
multiple functions required for survival of human T-cell leukemia virus type I-infected
T-cell lines and adult T-cell leukemia cells. Int. J. Cancer 120 (8), 1811–1820.
Kehn, K., Fuente Cde, L., Strouss, K., Berro, R., Jiang, H., Brady, J., Mahieux, R.,
Pumfery, A., Bottazzi, M.E., Kashanchi, F., 2005. The HTLV-I Tax oncoprotein
targets the retinoblastoma protein for proteasomal degradation. Oncogene 24
(4), 525–540.
Kim, S.J., Ding, W., Albrecht, B., Green, P.L., Lairmore, M.D., 2003. A conserved calcineurin-
bindingmotif inhumanT lymphotropic virus type1p12I functions tomodulate nuclear
factor of activated T cell activation. J. Biol. Chem. 278 (18), 15550–15557.
Kishi, S., Saijyo, S., Arai, M., Karasawa, S., Ueda, S., Kannagi, M., Iwakura, Y., Fujii, M.,
Yonehara, S., 1997. Resistance to fas-mediated apoptosis of peripheral T cells in
human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune
arthropathy. J. Exp. Med. 186 (1), 57–64.
Krueger, A., Baumann, S., Krammer, P.H., Kirchhoff, S., 2001. FLICE-inhibitory proteins:
regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 21 (24), 8247–8254.
Krueger, A., Fas, S.C., Giaisi, M., Bleumink, M., Merling, A., Stumpf, C., Baumann, S.,
Holtkotte, D., Bosch, V., Krammer, P.H., Li-Weber, M., 2006. HTLV-1 Tax protects
against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory
protein (c-FLIP). Blood 107 (10), 3933–3939.
Kwok, R.P., Laurance, M.E., Lundblad, J.R., Goldman, P.S., Shih, H., Connor, L.M., Marriott, S.J.,
Goodman, R.H., 1996. Control of cAMP-regulated enhancers by the viral transactivator
Tax through CREB and the co-activator CBP. Nature 380 (6575), 642–646.
Liu, Y., Wang, Y., Yamakuchi, M., Masuda, S., Tokioka, T., Yamaoka, S., Maruyama, I.,
Kitajima, I., 2001. Phosphoinositide-3 kinase-PKB/Akt pathway activation is
involved in ﬁbroblast Rat-1 transformation by human T-cell leukemia virus type I
tax. Oncogene 20 (20), 2514–2526.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time
quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (4), 402–408.
Matsuda, T., Almasan, A., Tomita, M., Uchihara, J.N., Masuda, M., Ohshiro, K., Takasu, N.,
Yagita, H., Ohta, T., Mori, N., 2005. Resistance to Apo2 ligand (Apo2L)/tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and
constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-
infected T-cell lines. J. Virol. 79 (3), 1367–1378.
Matsuoka, M., Jeang, K.T., 2007. Human T-cell leukaemia virus type 1 (HTLV-1)
infectivity and cellular transformation. Nat. Rev. Cancer 7 (4), 270–280.
McKinsey, T.A., Brockman, J.A., Scherer, D.C., Al-Murrani, S.W., Green, P.L., Ballard, D.W.,
1996. Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus
type 1: a potential mechanism for constitutive induction of NF-kappaB. Mol. Cell.
Biol. 16 (5), 2083–2090.
351L. Zane et al. / Virology 407 (2010) 341–351Mortreux, F., Kazanji, M., Gabet, A.S., de Thoisy, B., Wattel, E., 2001a. Two-step nature of
human T-cell leukemia virus type 1 replication in experimentally infected squirrel
monkeys (Saimiri sciureus). J. Virol. 75 (2), 1083–1089.
Mortreux, F., Leclercq, I., Gabet, A.S., Leroy, A., Westhof, E., Gessain, A., Wain-Hobson, S.,
Wattel, E., 2001b. Somatic mutation in human T-cell leukemia virus type 1 provirus
and ﬂanking cellular sequences during clonal expansion in vivo. J. Natl Cancer Inst.
93 (5), 367–377.
Nagai, M., Brennan, M.B., Sakai, J.A., Mora, C.A., Jacobson, S., 2001. CD8(+) T cells are an
in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98 (6),
1858–1861.
Okamoto, K., Fujisawa, J., Reth, M., Yonehara, S., 2006. Human T-cell leukemia virus
type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP
through activation of NF-kappaB. Genes Cells 11 (2), 177–191.
Pise-Masison, C.A., Choi, K.S., Radonovich, M., Dittmer, J., Kim, S.J., Brady, J.N., 1998.
Inhibition of p53 transactivation function by the human T-cell lymphotropic virus
type 1 Tax protein. J. Virol. 72 (2), 1165–1170.
Pomier, C., Alcaraz, M.T., Debacq, C., Lancon, A., Kerkhofs, P., Willems, L., Wattel, E.,
Mortreux, F., 2008. Early and transient reverse transcription during primary
deltaretroviral infection of sheep. Retrovirology 5, 16.
Pomier, C., Alcaraz, M.T., Debacq, C., Lancon, A., Kerkhofs, P., Willems, L., Wattel, E.,
Mortreux, F., 2009. A dose–effect relationship for deltaretrovirus-dependent
leukemogenesis in sheep. Retrovirology 6, 30.
Richardson, J.H., Hollsberg, P., Windhagen, A., Child, L.A., Haﬂer, D.A., Lever, A.M.,
1997. Variable immortalizing potential and frequent virus latency in blood-
derived T-cell clones infected with human T-cell leukemia virus type I. Blood 89
(9), 3303–3314.
Roy, N., Deveraux, Q.L., Takahashi, R., Salvesen, G.S., Reed, J.C., 1997. The c-IAP-1 and c-
IAP-2 proteins are direct inhibitors of speciﬁc caspases. EMBO J. 16 (23),
6914–6925.
Saggioro, D., Silic-Benussi, M., Biasiotto, R., D'Agostino, D.M., Ciminale, V., 2009. Control
of cell death pathways by HTLV-1 proteins. Front. Biosci. 14, 3338–3351.
Saito, M., Furukawa, Y., Kubota, R., Usuku, K., Izumo, S., Osame, M., Yoshida, M., 1996.
Mutation rates in LTR of HTLV-1 in HAM/TSP patients and the carriers are similarly
high to Tax/Rex-coding sequence. J. Neurovirol. 2 (5), 330–335 [see comments].
Schoemaker, M.H., Ros, J.E., Homan, M., Trautwein, C., Liston, P., Poelstra, K., van Goor,
H., Jansen, P.L., Moshage, H., 2002. Cytokine regulation of pro- and anti-apoptotic
genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2
(cIAP2) prevents apoptosis. J. Hepatol. 36 (6), 742–750.Sibon, D., Gabet, A.S., Zandecki, M., Pinatel, C., Thete, J., Delfau-Larue, M.H., Rabaaoui, S.,
Gessain, A., Gout, O., Jacobson, S., Mortreux, F., Wattel, E., 2006. HTLV-1 propels
untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from
death. J. Clin. Invest. 116 (4), 974–983.
Silic-Benussi, M., Cannizzaro, E., Venerando, A., Cavallari, I., Petronilli, V., La Rocca, N.,
Marin, O., Chieco-Bianchi, L., Di Lisa, F., D'Agostino, D.M., Bernardi, P., Ciminale, V.,
2009. Modulation of mitochondrial K(+) permeability and reactive oxygen species
production by the p13 protein of human T-cell leukemia virus type 1. Biochim.
Biophys. Acta 1787 (7), 947–954.
Silic-Benussi, M., Cavallari, I., Zorzan, T., Rossi, E., Hiraragi, H., Rosato, A., Horie, K.,
Saggioro, D., Lairmore, M.D., Willems, L., Chieco-Bianchi, L., D'Agostino, D.M.,
Ciminale, V., 2004. Suppression of tumor growth and cell proliferation by p13II, a
mitochondrial protein of human T cell leukemia virus type 1. Proc. Natl Acad. Sci.
USA 101 (17), 6629–6634.
Trevisan, R., Daprai, L., Paloschi, L., Vajente, N., Chieco-Bianchi, L., Saggioro, D., 2006.
Antiapoptotic effect of human T-cell leukemia virus type 1 tax protein correlates
with its creb transcriptional activity. Exp. Cell Res. 312 (8), 1390–1400.
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., Uchino, H., 1977. Adult T-cell leukemia:
clinical and hematologic features of 16 cases. Blood 50 (3), 481–492.
Waldele, K., Silbermann, K., Schneider, G., Ruckes, T., Cullen, B.R., Grassmann, R., 2006.
Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1
gene for the survival of transformed lymphocytes. Blood 107 (11), 4491–4499.
Wucherpfennig, K.W., Hollsberg, P., Richardson, J.H., Benjamin, D., Haﬂer, D.A., 1992. T-
cell activation by autologous human T-cell leukemia virus type I-infected T-cell
clones. Proc. Natl Acad. Sci. USA 89 (6), 2110–2114.
Yamano, Y., Nagai, M., Brennan, M., Mora, C.A., Soldan, S.S., Tomaru, U., Takenouchi, N.,
Izumo, S., Osame,M., Jacobson, S., 2002. Correlation of human T-cell lymphotropic virus
type 1 (HTLV-1) mRNA with proviral DNA load, virus-speciﬁc CD8(+) T cells, and
disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99 (1), 88–94.
Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M., Horvitz, H.R., 1993. The C. elegans cell death
gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting
enzyme. Cell 75 (4), 641–652.
Zane, L., Sibon, D., Jeannin, L., Zandecki, M., Delfau-Larue, M.H., Gessain, A., Gout, O.,
Pinatel, C., Lancon, A., Mortreux, F., Wattel, E., 2010. Tax gene expression and cell
cycling but not cell death are selected during HTLV-1 infection in vivo.
Retrovirology 7, 17.
Zane, L., Sibon, D., Mortreux, F., Wattel, E., 2009. Clonal expansion of HTLV-1 infected
cells depends on the CD4 versus CD8 phenotype. Front. Biosci. 14, 3935–3941.
